DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rozerem (Ramelteon) - Adverse Event Reports - Death

 



Index of reports > Cases resulting in death (7)

     Completed Suicide (3)Vomiting (2)Respiratory Failure (2)Aspiration (2)Incorrect Dose Administered (1)Wrong Drug Administered (1)Depressed Level of Consciousness (1)Self-Medication (1)

Below is the selection of adverse event reports related to Rozerem (Ramelteon) that includes cases resulting in death.

Adverse event in 45 year old male receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: 45 year old male

Adverse reactions / side effects: Wrong Drug Administered, Self-Medication

Adverse event resulted in: death

Suspect drug(s):
Rozerem (Ramelteon)



Adverse event in receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-05-23

Patient:

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Rozerem (Ramelteon)



Adverse event in 30 year old female receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-05-03

Patient: 30 year old female, weighing 87.5 kg (192.6 pounds)

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death

Suspect drug(s):
Rozerem (Ramelteon)



Adverse event in female receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-05-01

Patient: female

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Divorced
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Mental Disorder
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Stress
    Start date: 2007-04-01
    End date: 2007-04-01



Adverse event in female receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-04-26

Patient: female

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-04-01
    End date: 2007-04-01

Rozerem
    Dosage: per oral
    Administration route: Oral
    Indication: Stress
    Start date: 2007-04-01
    End date: 2007-04-01



Adverse event in 27 year old male receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-02-16

Patient: 27 year old male

Adverse reactions / side effects: Vomiting, Aspiration, Respiratory Failure, Incorrect Dose Administered, Depressed Level of Consciousness

Adverse event resulted in: death

Suspect drug(s):
Rozerem
    Dosage: 1 tab., per oral
    Administration route: Oral
    Indication: Insomnia

Ambien
    Dosage: 10 mg, 2-3 doses
    Indication: Insomnia

Ambien
    Dosage: 10 mg, 2-3 doses
    Indication: Mental Disorder

Other drugs received by patient: Zoloft



Adverse event in 27 year old male receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-02-12

Patient: 27 year old male

Adverse reactions / side effects: Vomiting, Aspiration, Respiratory Failure

Adverse event resulted in: death

Suspect drug(s):
Rozerem
    Dosage: per oral
    Indication: Insomnia

Ambien
    Indication: Insomnia

Ambien
    Indication: Mental Disorder

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009